A Risk-Based Approach for Safety Case Follow-up of Adverse Event Reports in Pharmacovigilance (vol 41, pg 82, 2024)

被引：0

作者：

Vemula, Ganesh Kumar ^{[1
]}

Badale, Pavan ^{[1
]}

Mavrogenis, Petros ^{[2
]}

Lalande-Luesink, Isabelle ^{[2
]}

Borkowski, Michal ^{[2
]}

Lewis, David John ^{[2
]}

机构：

[1] Novartis Pharma AG, Patient Safety & Pharmacovigilance, Dev, Hyderabad, India

[2] Novartis Pharma AG, Patient Safety & Pharmacovigilance, Dev, Basel, Switzerland

来源：

ADVANCES IN THERAPY | 2024年 / 41卷 / 02期

关键词：

D O I：

10.1007/s12325-023-02751-3

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：883 / 883

页数：1

共 19 条

[1] A Risk-Based Approach for Safety Case Follow-up of Adverse Event Reports in Pharmacovigilance
Ganesh Kumar Vemula
Pavan Badale
Petros Mavrogenis
Isabelle Lalande-Luesink
Michal Borkowski
David John Lewis
Advances in Therapy, 2024, 41 : 82 - 91
[2] A Risk-Based Approach for Safety Case Follow-up of Adverse Event Reports in Pharmacovigilance
Vemula, Ganesh Kumar
Badale, Pavan
Mavrogenis, Petros
Lalande-Luesink, Isabelle
Borkowski, Michal
Lewis, David John
ADVANCES IN THERAPY, 2024, 41 (01) : 82 - 91
[3] Arthritis after Lyme vaccine selected emidemiologic features based on follow-up evaluations of vaccine adverse event reporting system (VAERS) reports
Shadomy, SV
Ball, R
Woo, J
Miller, FW
Braun, MM
ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S230 - S230
[4] Evaluation of a risk-based approach to follow-up care for breast cancer survivors: From oncology specialist to primary care provider (PCP).
Keenan, Kathleen
Dunne, Megan
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[5] Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study (vol 70, pg 1083, 2011)
Ruffatti, Amelia
Del Ross, Teresa
Ciprian, Manuela
Sciascia, Savino
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (08)
[6] Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study (vol 8, pg 1415, 2024)
Mitami, K.
Lee, J. W.
Jang, J. H.
BLOOD ADVANCES, 2024, 8 (23) : 6097 - 6097
[7] The randomised Oslo study of renal denervation vs. antihypertensive drug adjustments: efficacy and safety through 7 years of follow-up (vol 30, pg 41, 2020)
Bergland, O. U.
Soraas, C. L.
Larstorp, A. C. K.
Halvorsen, L. V.
Hjornholm, U.
Hoffman, P.
Hoieggen, A.
Elmula, F. E. M. F.
BLOOD PRESSURE, 2021, 30 (04) : 265 - 265
[8] The effects of sleep duration on the risk of dementia incidence in short and long follow-up studies: A systematic review and meta-analysis (vol 124, pg 522, 2024)
Howard, Connie
Mukadam, Naaheed
Hui, Esther K.
Livingston, Gill
SLEEP MEDICINE, 2025, 129 : 131 - 131
[9] Risk factors for postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas based on a long-term follow-up study: proposals for follow-up strategies. (vol 22, pg 757, 2015)
Yogi, T.
Hijioka, S.
Imaoka, H.
Mizuno, N.
Hara, K.
Tajika, M.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2017, 24 (01) : 72 - 73
[10] Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use (vol 41, pg 491, 2006)
Knopp, M. V.
Balzer, T.
Esser, M.
INVESTIGATIVE RADIOLOGY, 2006, 41 (09) : 667 - 667

← 1 2 →